Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma-Reference-Cited by-同舟云学术

Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma

Published:2011-10-04 Issue:5 Volume:75 Page:585-591
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Kroiss Matthias,Quinkler Marcus,Lutz Werner K.,Allolio Bruno,Fassnacht Martin

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2011.04214.x/fullpdf

Reference77 articles.

1. Adrenocortical carcinoma: a clinician’s update;Fassnacht;Nature Reviews Endocrinology,2011

2. Regression of adrenal cancer and suppression of adrenal function in men by o,p-DDD;Bergenstal;Transactions of theAssociation of American Physicians,1959

3. Adjuvant mitotane treatment for adrenocortical carcinoma;Terzolo;New England Journal of Medicine,2007

4. Mitotane for adrenocortical carcinoma treatment;Hahner;Current Opinion in Investigational Drugs,2005

5. Mitotane has a strong and a durable inducing effect on CYP3A4 activity;van Erp;European Journal of Endocrinology,2011

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma;Frontiers in Endocrinology;2024-01-09

2. Adrenocortical cancer: late diagnosis of the disease on the example of a clinical case. Case report;Terapevticheskii arkhiv;2023-12-28

3. Recommandations conjointes du réseau National ENDOCAN-COMETE, de l’Association francophone de chirurgie endocrinienne et de la Société française d’urologie pour la prise en charge du carcinome corticosurrénalien;Bulletin du Cancer;2023-06

4. Adrenocortical Carcinoma;Surgical Oncology Clinics of North America;2023-04

5. Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets;Frontiers in Endocrinology;2023-01-30